SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
NEKTAR THERAPEUTICS
(NQNM:NKTR Last Sale: 19.07 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (NKTR : $19.07)
$3,386,015 million Market Cap at Market Close, July 1, 2022
Employs 340.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

150 Industrial Road Research Report Earnings Snapshot - Last 11/06/18
San Carlos, CA 94070 Fact Sheet
Phone: 650-631-3100 Financial Statements
Peer Comparison
Annual Reports

Robert B. Chess, Ex. Chmn., Howard W. Robin, CEO/Pres., John Nicholson, CFO
Developing a pulmonary drug delivery system applicable to a wide range of peptides, proteins, and other macromolecules currently delivered by injection. Acquired AEROGEN INC (AEGN) October 20, 2005 for $0.75 per share. Formerly, INHALE THERAPEUTIC SYSTEMS (INHL). Founded in 1990.
Historical Charts    Technical Analysis
No Historical Data available for NKTR

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common NKTR $19.07 $19.07 0 .0 $17.63 $19.08 1,088,008 $17.63 $19.08 177,557,144
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
15-JAN-03 INHL Symbol Changed to NKTR
22-AUG-00 INHL Split 2 for 1

A321
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex